[Reske SN. Nuclear imaging of prostate cancer: current status. Urologe A 2007; 46: 1485-99.10.1007/s00120-007-1572-617932641]Search in Google Scholar
[Kragelj B. Increased late urinary toxicity with whole pelvic radiotherapy after prostatectomy. Radiol Oncol 2009; 43: 88-96.10.2478/v10019-009-0014-z]Search in Google Scholar
[Avazpour I, Roslan RE, Bayat P, Saripan MI, Nordin AJ, Abdullah RSAR. Segmenting CT images of bronchogenic carcinoma with bone metastases using PET intensity markers approach. Radiol Oncol 2009; 43: 180-6.10.2478/v10019-009-0023-y]Search in Google Scholar
[Naji M, Hodolic M, El-Refai S, Khan S, Marzola MC, Rubello D, et al. Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management. J Endocrinol Invest 2010; 33: 54-60.10.1007/BF0334655019820296]Search in Google Scholar
[Watanabe H, Kanematsu M, Kondo H, Kako N, Yamamoto N, Yamada T, et al. Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging. J Magn Reson Imaging 2010; 31: 1151-6.10.1002/jmri.2215720432351]Search in Google Scholar
[Talbot JN, Gutman F, Huchet V, Kerrou K, Balogova S, Kerrouche N, et al. [Clinical usefulness of positron emission tomography in prostate cancer]. [French]. Presse Med 2007; 36: 1794-806.10.1016/j.lpm.2007.02.03017524607]Search in Google Scholar
[Schillaci O, Calabria F, Tavolozza M, Ciccio C, Carlani M, Caracciolo CR, et al. 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer. Nucl Med Commun 2010; 31: 39-4.10.1097/MNM.0b013e328330adc519972635]Search in Google Scholar
[Le C, van de Weijer EP, Pos FJ, Vogel W. Active inflammation in 18F-methylcholine PET/CT. Eur J Nucl Med Mol Imaging 2010; 37: 654-5.10.1007/s00259-009-1329-0282222820016891]Search in Google Scholar
[Kwee SA, Wei H, Sesterhenn I, Yun D, Coel MN. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. J Nucl Med 2006; 47: 262-9.]Search in Google Scholar
[Steiner Ch, Vees H, Zaidi H, Wissmeyer M, Berrebi O, Kossovsky MP, et al. Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence. Nuklearmedizin 2009; 48: 1-9.10.3413/nukmed-019419212605]Search in Google Scholar
[Langsteger W, Heinisch M, Fogelman I. The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med 2006; 36: 73-92.10.1053/j.semnuclmed.2005.09.00216356797]Search in Google Scholar
[Beheshti M, Imamovic L, Broinger G, Vali R, Waldenberger P, Stoiber F, et al. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients. Radiology 2010; 254: 925-33.10.1148/radiol.0909041320177103]Search in Google Scholar
[Igerc I, Kohlfurst S, Gallowitsch HJ, Matschnig S, Kresnik E, Gomez-Segovia I, et al. The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer. Eur J Nucl Med Mol Imaging 2008; 35: 976-83.10.1007/s00259-007-0686-918188560]Search in Google Scholar
[Beheshti M, Vali R, Waldenberger P, Fitz F, Nader M, Loidl W, et al. Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study. Eur J Nucl Med Mol Imaging 2008; 35: 1766-74.10.1007/s00259-008-0788-z18465129]Search in Google Scholar
[Horvat AG, Kovac V, Strojan P. Radiotherapy in palliative treatment of painful bone metastases. Radiol Oncol 2009; 43: 213-24.10.2478/v10019-009-0038-4]Search in Google Scholar
[Reske SN; Blumstein NM; Glatting G. PET and PET/CT in relapsing prostate carcinoma. Urologe A 2006; 45: 1240-50.10.1007/s00120-006-1212-617006698]Search in Google Scholar
[Pelosi E, Arena V, Skanjeti A, Pirro V, Douroukas A, Pupi A, et al. Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer. Radiol Med 2008; 113: 895-904.10.1007/s11547-008-0263-818414809]Search in Google Scholar
[Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T, et al. [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006; 33: 1387-98.10.1007/s00259-006-0150-216865395]Search in Google Scholar
[Yamamoto Y, Nishiyama Y, Kameyama R, Okano K, Kashiwagi H, Deguchi A, et al. Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET. J Nucl Med 2008; 49: 1245-8.10.2967/jnumed.108.05263918632827]Search in Google Scholar